HIV-2 capsids distinguish high and low virus load patients in a West African community cohort

Vaccine

Volumn 28, Issue SUPPL. 2, 2010, Pages

  Onyango, Clayton O ^a   Leligdowicz, Aleksandra ^a,b   Yokoyama, Masaru ^c   Sato, Hironori ^c   Song, Haihan ^d   Nakayama, Emi E ^d   Shioda, Tatsuo ^d   de Silva, Thushan ^a   Townend, John ^a   Jaye, Assan ^a   Whittle, Hilton ^a   Rowland Jones, Sarah ^a,b   Cotten, Matthew ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Capsid; HIV 2; TRIM5

Indexed keywords

PROLINE; PROLINE P26; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AFRICA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 CAPSID; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

CAPSID; CARRIER PROTEINS; COHORT STUDIES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GUINEA-BISSAU; HIV INFECTIONS; HIV-2; HUMANS; MODELS, MOLECULAR; PHYLOGENY; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, PROTEIN; VIRAL LOAD; VIRUS REPLICATION;

EID: 77952607659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.060     Document Type: Article

References (50)

1. Barin F., M'Boup S., Denis F., Kanki P., Allan J.S., Lee T.H., et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 2 8469-70 (1985) 1387-1389
2. Clavel F., Guetard D., Brun-Vezinet F., Chamaret S., Rey M.A., Santos-Ferreira M.O., et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 233 4761 (1986) 343-346
3. Lemey P., Pybus O.G., Wang B., Saksena N.K., Salemi M., and Vandamme A.M. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 100 11 (2003) 6588-6592
4. Rowland-Jones S.L., and Whittle H.C. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?. Nat Immunol 8 4 (2007) 329-331
5. Poulsen A.G., Kvinesdal B., Aaby P., Molbak K., Frederiksen K., Dias F., et al. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1 8642 (1989) 827-831
6. Berry N., Ariyoshi K., Balfe P., Tedder R., and Whittle H. Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b. AIDS Res Hum Retroviruses 17 3 (2001) 263-267
7. Berry N., Ariyoshi K., Jaffar S., Sabally S., Corrah T., Tedder R., et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1 7 (1998) 457-468
8. Ariyoshi K., Jaffar S., Alabi A.S., Berry N., Schim van der Loeff M., Sabally S., et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 14 4 (2000) 339-344
9. Gao F., Yue L., Robertson D.L., Hill S.C., Hui H., Biggar R.J., et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 68 11 (1994) 7433-7447
10. Ricard D., Wilkins A., N'Gum P.T., Hayes R., Morgan G., Da Silva A.P., et al. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 8 7 (1994) 977-982
11. Grassly N.C., Xiang Z., Ariyoshi K., Aaby P., Jensen H., Schim van der Loeff M., et al. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. J Virol 72 10 (1998) 7895-7899
12. Norrgren H., Marquina S., Leitner T., Aaby P., Melbye M., Poulsen A.G., et al. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau. J Acquir Immune Defic Syndr Hum Retrovirol 16 1 (1997) 31-38
13. Padua E., Jenkins A., Brown S., Bootman J., Paixao M.T., Almond N., et al. Natural variation of the Nef gene in human immunodeficiency virus type 2 infections in Portugal. J Gen Virol 84 Pt 5 (2003) 1287-1299
14. Leligdowicz A., Yindom L.M., Onyango C., Sarge-Njie R., Alabi A., Cotten M., et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 117 10 (2007) 3067-3074
15. Mortuza G.B., Haire L.F., Stevens A., Smerdon S.J., Stoye J.P., and Taylor I.A. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431 7007 (2004) 481-485
16. Briggs J.A., Grunewald K., Glass B., Forster F., Krausslich H.G., and Fuller S.D. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 14 1 (2006) 15-20
17. Ganser B.K., Li S., Klishko V.Y., Finch J.T., and Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 283 5398 (1999) 80-83
18. Ganser-Pornillos B.K., Yeager M., and Sundquist W.I. The structural biology of HIV assembly. Curr Opin Struct Biol 18 2 (2008) 203-217
19. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278 5339 (1997) 849-853
20. Mammano F., Ohagen A., Hoglund S., and Gottlinger H.G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J Virol 68 8 (1994) 4927-4936
21. Alabi A.S., Jaffar S., Ariyoshi K., Blanchard T., Schim van der Loeff M., Awasana A.A., et al. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 17 10 (2003) 1513-1520
22. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41 (1999) 95-98
23. Song H., Nakayama E.E., Yokoyama M., Sato H., Levy J.A., and Shioda T. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J Virol 81 13 (2007) 7280-7285
24. Kinomoto M., Yokoyama M., Sato H., Kojima A., Kurata T., Ikuta K., et al. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor. J Virol 79 10 (2005) 5996-6004
25. Kinomoto M., Appiah-Opong R., Brandful J.A., Yokoyama M., Nii-Trebi N., Ugly-Kwame E., et al. HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. Clin Infect Dis 41 2 (2005) 243-251
26. Shirakawa K., Takaori-Kondo A., Yokoyama M., Izumi T., Matsui M., Io K., et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 15 11 (2008) 1184-1191
27. Monaco-Malbet S., Berthet-Colominas C., Novelli A., Battai N., Piga N., Cheynet V., et al. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure 8 10 (2000) 1069-1077
28. Baker D., and Sali A. Protein structure prediction and structural genomics. Science 294 5540 (2001) 93-96
29. Ponder J.W., and Case D.A. Force fields for protein simulations. Adv Protein Chem 66 (2003) 27-85
30. Lee K., and Chu C.K. Molecular modelling approach to understanding the mode of action of l-nucleosides as antiviral agents. Antimicrob Agents Chemother 45 1 (2001) 138-144
31. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., and Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326 6114 (1987) 662-669
32. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old World monkeys. Nature 427 6977 (2004) 848-853
33. Goff S.P. HIV: replication trimmed back. Nature 427 6977 (2004) 791-793
34. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J.P., and Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA 97 22 (2000) 12295-12299
35. Stremlau M. GE Prize-winning essay, Why old World monkeys are resistant to HIV-1. Science 318 5856 (2007) 1565-1566
36. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., and Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 99 18 (2002) 11914-11919
37. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 103 14 (2006) 5514-5519
38. Creighton T.E. Proteins: Structures and Molecular Properties. 2nd ed. (1992), W.H. Freeman, New York
39. Howard B.R., Vajdos F.F., Li S., Sundquist W.I., and Hill C.P. Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol 10 6 (2003) 475-481
40. Berry N., Jaffar S., Schim van der Loeff M., Ariyoshi K., Harding E., N'Gom P.T., et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses 18 16 (2002) 1167-1173
41. Moore C.B., John M., James I.R., Christiansen F.T., Witt C.S., and Mallal S.A. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296 5572 (2002) 1439-1443
42. Brumme Z.L., Tao I., Szeto S., Brumme C.J., Carlson J.M., Chan D., et al. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 22 11 (2008) 1277-1286
43. Bhattacharya T., Daniels M., Heckerman D., Foley B., Frahm N., Kadie C., et al. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315 5818 (2007) 1583-1586
44. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458 7238 (2009) 641-645
45. Klenerman P., and McMichael A. AIDS/HIV. Finding footprints among the trees. Science 315 5818 (2007) 1505-1507
46. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16 2 (1980) 111-120
47. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24 8 (2007) 1596-1599
48. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 4 (1987) 406-425
49. Tamura K., Nei M., and Kumar S. Prospects for inferring very large phylogenies by using the neighbour-joining method. Proc Natl Acad Sci USA 101 30 (2004) 11030-11035
50. Wilkins A., Ricard D., Todd J., Whittle H., Dias F., and Paulo Da Silva A. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS 7 8 (1993) 1119-1122